Table 1 Clinical characteristics of breast cancer patients
From: E-cadherin genetic variants predict survival outcome in breast cancer patients
Characteristics | Patients (%) |
|---|---|
Total | 577 |
Age at diagnosis | |
 ≤40 | 133 (23.1) |
 >40 | 444 (76.9) |
Menopausal status | |
 Non menopausal | 298 (51.6) |
 Menopausal | 279 (48.4) |
Tumor size | |
 T1–T2 | 381 (66) |
 T3–T4 | 167 (29) |
 Unknown | 29 (5) |
Lymph node involvement | |
 Negative | 230 (39.9) |
 Positive | 328 (56.8) |
 Unknown | 19 (3.3) |
Metastasis | |
 Negative | 362 (62.7) |
 Positive | 10 (1.7) |
 Unknown | 205 (35.5) |
SBR grade | |
 SBR 1–2 | 329 (57) |
 SBR 3 | 192 (33.3) |
 Unknown | 56 (9.7) |
Histology | |
 Ductual | 513 (88.9) |
 Lobular | 23 (4) |
 Other | 25 (4.3) |
 Unknown | 16 (2.8) |
Estrogen receptor | |
 Negative | 195 (33.8) |
 Positive | 255 (44.2) |
 Unknown | 127 (22) |
Progesteron receptor | |
 Negative | 240 (41.6) |
 Positive | 210 (36.4) |
 Unknown | 127 (22) |
Her-2 status | |
 Negative | 75 (13) |
 Positive | 39 (6.8) |
 Unknown | 463 (80.2) |